Aurora Capital is both a boutique investment banking firm specializing in the life sciences sector and a full-service brokerage firm. The firm advises in the areas of private placements, bridge finance, mergers, acquisitions, licensing, joint ventures, reverse mergers and convertible debt. Aurora's public securities brokerage division offers a wide range of brokerage transaction capabilities across a number of different securities and investment types. Aurora was founded in 1994 and is based in New York, New York. The firm has been registered as a broker-dealer with the U.S. Securities and Exchange Commission and is a member of FINRA, MSRB and SIPC.